Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Feb 14, 2020
Total Value: $1.387B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma A/S | 1,109,874 | $154M | 11.1% | $139.12 | $69.98 | — | ADR | 04351P101 |
| — | Nextcure, Inc | 2,671,856 | $151M | 10.8% | $56.33 | $17.30 | — | COMM | 65343E108 |
| — | Karuna Therapeutics, Inc. | 1,885,602 | $142M | 10.2% | $75.34 | $24.60 | — | COMM | 48576A100 |
| — | Amarin | 5,208,305 | $112M | 8.0% | $21.44 | $7.81 | — | ADR | 023111206 |
| NTRA | Natera | 3,100,560 | $104M | 7.5% | $33.69 * | $9.81 | +275.8% | COMM | 632307104 |
| — | Principia Biopharma | 1,417,258 | $77.64M | 5.6% | $54.78 | $28.92 | — | COMM | 74257L108 |
| — | Y-mAbs Therapeutics, Inc | 2,194,278 | $68.57M | 4.9% | $31.25 | $26.75 | — | COMM | 984241109 |
| GRTX | Galera Therapeutics, Inc | 3,083,712 | $40.58M | 2.9% | $13.16 * | $12.19 | 0.0% | COMM | 36338D108 |
| BMRN | Biomarin Pharmaceutical Inc | 441,872 | $37.36M | 2.7% | $84.55 * | $77.86 | -3.0% | COMM | 09061G101 |
| CHRS | Coherus BioSciences | 1,933,221 | $34.81M | 2.5% | $18.01 * | $10.94 | +68.6% | COMM | 19249H103 |
| VRTX | Vertex Pharmaceuticals Inc | 139,164 | $30.47M | 2.2% | $218.95 * | $179.35 | +12.8% | COMM | 92532F100 |
| — | Merus N.V. | 1,961,039 | $27.61M | 2.0% | $14.08 | $18.53 | — | COMM | N5749R100 |
| PTCT | PTC Therapeutics Inc | 517,092 | $24.84M | 1.8% | $48.03 * | $40.82 | +4.1% | COMM | 69366J200 |
| MRK | Merck & Co Inc | 240,806 | $21.9M | 1.6% | $90.95 * | $67.55 | 0.0% | COMM | 58933Y105 |
| BIIB | Biogen Inc | 63,711 | $18.9M | 1.4% | $296.71 * | $277.46 | 0.0% | COMM | 09062X103 |
| REGN | Regeneron Pharmaceuticals Inc | 50,086 | $18.81M | 1.4% | $375.47 * | $334.59 | 0.0% | COMM | 75886F107 |
| — | ObsEva SA | 4,749,623 | $18.14M | 1.3% | $3.82 | $13.49 | — | COMM | H5861P103 |
| UTHR | United Therapeutics Corp | 188,645 | $16.62M | 1.2% | $88.08 | $80.53 | +9.3% | COMM | 91307C102 |
| — | ChemoCentryx Inc | 376,944 | $14.91M | 1.1% | $39.55 | $39.55 | — | COMM | 16383L106 |
| — | Nucana Biomed Ltd | 2,400,000 | $14.64M | 1.1% | $6.10 | $19.00 | — | Ordinary Shares | GB00BYWYV |
| — | MyoKardia Inc | 195,871 | $14.28M | 1.0% | $72.88 | $60.83 | — | COMM | 62857M105 |
| — | Mirati Therapeutics Inc | 108,383 | $13.97M | 1.0% | $128.86 | $114.37 | — | COMM | 60468T105 |
| — | Nucana Biomed Ltd | 2,266,666 | $13.83M | 1.0% | $6.10 | $15.80 | — | ADR | 67022C106 |
| MGNX | MacroGenics Inc | 1,173,882 | $12.77M | 0.9% | $10.88 * | $13.33 | -25.8% | COMM | 556099109 |
| FATE | Fate Therapeutics Inc | 635,143 | $12.43M | 0.9% | $19.57 * | $17.86 | -11.1% | COMM | 31189P102 |
| — | Alnylam Pharmaceuticals Inc | 100,000 | $11.52M | 0.8% | $115.17 | — | — | Call | 02043Q907 |
| SRPT | Sarepta Therapeutics Inc | 87,818 | $11.33M | 0.8% | $129.04 * | $118.10 | -14.5% | COMM | 803607100 |
| — | Kadmon Holdings Inc | 2,368,958 | $10.73M | 0.8% | $4.53 | $2.74 | — | COMM | 48283N106 |
| — | Kiniksa Pharmaceuticals, Ltd | 922,700 | $10.21M | 0.7% | $11.06 | $17.35 | — | COMM CL A | G5269C101 |
| — | Medicines Co | 110,000 | $9.343M | 0.7% | $84.94 | — | — | Put | 584688955 |
| TGTX | TG Therapeutics Inc | 811,292 | $9.006M | 0.6% | $11.10 * | $6.96 | +9.2% | COMM | 88322Q108 |
| — | Calithera Biosciences Inc | 1,458,821 | $8.331M | 0.6% | $5.71 | $4.27 | — | COMM | 13089P101 |
| — | Dermira Inc | 545,466 | $8.27M | 0.6% | $15.16 | $8.90 | — | COMM | 24983L104 |
| — | Alexion Pharmaceuticals Inc | 75,000 | $8.112M | 0.6% | $108.16 | — | — | Call | 015351909 |
| — | Chiasma | 1,630,221 | $8.086M | 0.6% | $4.96 | $1.49 | — | COMM | 16706W102 |
| — | Acceleron Pharma Inc | 147,032 | $7.796M | 0.6% | $53.02 | $40.44 | — | COMM | 00434H108 |
| — | Iterum Therapeutics | 1,726,514 | $7.769M | 0.6% | $4.50 | $10.89 | — | COMM | G6333L101 |
| — | ArQule Inc | 387,469 | $7.734M | 0.6% | $19.96 | $5.46 | — | COMM | 04269E107 |
| BCRX | BioCryst Pharmaceuticals Inc | 2,151,164 | $7.421M | 0.5% | $3.45 * | $3.23 | -22.2% | COMM | 09058V103 |
| — | Entasis Therapeutics Holdings Inc. | 1,180,178 | $5.865M | 0.4% | $4.97 | $10.88 | — | COMM | 293614103 |
| — | Otonomy Inc | 1,515,629 | $5.804M | 0.4% | $3.83 | $2.85 | — | COMM | 68906L105 |
| — | Seattle Genetics Inc | 50,000 | $5.712M | 0.4% | $114.24 | $114.24 | — | COMM | 812578102 |
| — | Forty Seven Inc | 138,643 | $5.458M | 0.4% | $39.37 | $7.38 | — | COMM | 34983P104 |
| — | Zymeworks Inc | 107,552 | $4.889M | 0.4% | $45.46 | $22.00 | — | COMM | 98985W102 |
| FOLD | Amicus Therapeutics Inc | 475,330 | $4.63M | 0.3% | $9.74 * | $12.56 | -27.1% | COMM | 03152W109 |
| XBIT | XBiotech Inc | 240,995 | $4.498M | 0.3% | $18.66 * | $7.09 | +56.5% | COMM | 98400H102 |
| — | Orchard Therapeutics PLC | 283,406 | $3.897M | 0.3% | $13.75 | $15.62 | — | ADR | 68570P101 |
| — | Foamix Pharmaceuticals Ltd | 1,162,176 | $3.87M | 0.3% | $3.33 | $4.42 | — | COMM | M46135105 |
| — | Applied Therapeutics Inc | 134,825 | $3.678M | 0.3% | $27.28 | $8.24 | — | COMM | 03828A101 |
| ACRS | Aclaris Therapeutics | 1,911,573 | $3.613M | 0.3% | $1.89 * | $19.07 | -91.3% | COMM | 00461U105 |
| — | Dicerna Pharmaceuticals Inc | 159,512 | $3.514M | 0.3% | $22.03 | $14.36 | — | COMM | 253031108 |
| — | Kala Pharmaceuticals Inc | 664,641 | $2.453M | 0.2% | $3.69 | $4.90 | — | COMM | 483119103 |
| APLS | Apellis Pharmaceuticals, Inc | 49,580 | $1.518M | 0.1% | $30.62 * | $19.65 | +40.8% | COMM | 03753U106 |
| — | Synlogic Inc. | 574,972 | $1.483M | 0.1% | $2.58 | $9.38 | — | COMM | 87166L100 |
| — | Homology Medicines Inc | 64,397 | $1.332M | 0.1% | $20.68 | $18.09 | — | COMM | 438083107 |
| HALO | Halozyme Therapeutics Inc | 72,481 | $1.285M | 0.1% | $17.73 * | $16.18 | +7.1% | COMM | 40637H109 |
| HRTX | Heron Therapeutics Inc | 50,500 | $1.187M | 0.1% | $23.50 * | $25.45 | -13.1% | COMM | 427746102 |
| RYTM | Rhythm Pharmaceuticals Inc | 21,319 | $489K | 0.0% | $22.94 * | $22.21 | 0.0% | COMM | 76243J105 |
| PDSB | PDS Biotechnology Corporation | 142,635 | $378K | 0.0% | $2.65 * | $8.36 | -65.9% | COMM | 70465T107 |